Showing 941 - 960 results of 1,932 for search '"Five Ranks', query time: 0.11s Refine Results
  1. 941

    Proprioceptive Reweighting and Postural Control are Impaired Among Elite Athletes Following Anterior Cruciate Ligament Reconstruction by Benoit Attalin, Telma Sagnard, Eric Laboute, Nicolas Forestier, Olivier Rémy-Néris, Brice Picot

    Published 2024-11-01
    “… # Results The eRPW was higher in the ACLR group (100.9±58.8 vs. 68.6±26.6%; p=0.031; Rank biserial correlation=0.314; medium), with a greater proportion of rigid athletes than in the control group (38.5 vs. 4.4%; p=0.010), reflecting lower proprioceptive reweighting. …”
    Get full text
    Article
  2. 942
  3. 943
  4. 944
  5. 945

    Investigation of flood capability in Jafarabad basin by Shamsollah Asgari, Amir Safari

    Published 2018-03-01
    “…The data of 28 sub-basin variables were analyzed by SPSS software and summarized in 5 main factors (shape, flow, slope, drainage and runoff). …”
    Get full text
    Article
  6. 946

    Multi-scenario modeling of regional dual-carbon target achievement and air quality improvement: A case study of Zhejiang province by Yuxin Yang

    Published 2025-01-01
    “…The results indicate that (1) the industrial, transport, and residential sectors contribute over 84.7% of energy consumption, CO2 emissions, and air pollutant emissions from 2020 to 2060, identifying them as key targets for mitigation strategies; (2) carbon peaking is not projected under the baseline scenario, but is expected by 2040 in the low-carbon scenario and 2029 in the deep low-carbon scenario, with a peak emission of 208.821 million tons, primarily driven by reductions in the industrial sector; (3) air pollutant emissions across scenarios rank as O3, NO2, PM10, PM2.5, and SO2, indicating the need for stronger O3 control; and (4) the proportion of days meeting national air quality standards remains unchanged, implying further action is necessary to improve air quality. …”
    Get full text
    Article
  7. 947

    Mycobacterium tuberculosis Lineage Distribution Using Whole-Genome Sequencing and Bedaquiline, Clofazimine, and Linezolid Phenotypic Profiles among Rifampicin-Resistant Isolates fr... by Andriansjah Rukmana, Cynthia Gozali, Linda Erlina

    Published 2024-01-01
    “…Tuberculosis (TB) is caused by Mycobacterium tuberculosis infection. Indonesia is ranked second in the world for TB cases. New anti-TB drugs from groups A and B, such as bedaquiline, clofazimine, and linezolid, have been shown to be effective in curing drug resistance in TB patients, and Indonesia is already using these drugs to treat patients. …”
    Get full text
    Article
  8. 948

    Satisfactory Functional Outcome and Significant Correlation with the Length of Haglund’s Deformity after Endoscopic Calcaneoplasty: A Minimum 4-Year Follow-Up Study by Hossam Fathi Mahmoud, Walid Feisal, Fahmy Samir Fahmy

    Published 2022-01-01
    “…The paired t test and the Wilcoxon signed-rank test compared the preoperative and final postoperative means. …”
    Get full text
    Article
  9. 949

    The Association Between Mitral Regurgitation and Long-Term Outcomes in Acute Myocardial Infarction Undergoing Percutaneous Coronary Intervention: A Retrospective Large Sample Cohor... by Yan N, Wu P, Zhu B, Ma A, Wang X, Hai X, Ma X, Jiang H, Yang S

    Published 2025-02-01
    “…Cox regression models were employed to analyze the association between MR and 3-year clinical outcomes after adjusting for various confounding factors.Results: Among the 6940 patients, 2871 (41.35%) exhibited no MR, 3681 (53.04%) had mild MR, and 388 (5.59%) had moderate/severe MR. The cumulative 3-year incidence of MACCEs was 19.21% overall, with rates of 15.26%, 20.37%, and 37.37% in the no MR, mild MR, and moderate/severe MR groups, respectively (log-rank p < 0.001). …”
    Get full text
    Article
  10. 950

    Treatment and Outcomes of Pancreatic Cancer in Armenia: A Retrospective Study From Resource-Limited Settings by Elen Baloyan, Davit Zohrabyan, Liana Safaryan, Armen Avagyan, Lilit Harutyunyan, Vardan Bardakhchyan, Jemma Arakelyan, Amalya Sargsyan, Martin Harutyunyan, Mariam Mailyan, Gevorg Tamamyan, Samvel Bardakhchyan

    Published 2025-01-01
    “…The median OS was 11 months (range, 2-169 months): In stages I-III, patients who had surgery (44.4%) lived significantly longer than those who did not (20 v 11 months; P = .008). Main chemotherapy regimens were 5-fluorouracil, oxaliplatin, folinic acid and irinotecan (41.4%) and gemcitabine plus capecitabine (38.6%). …”
    Get full text
    Article
  11. 951
  12. 952
  13. 953
  14. 954
  15. 955
  16. 956
  17. 957
  18. 958
  19. 959
  20. 960